Bacteria News and Research

RSS

Beetroot peptide may be a good candidate for development of a drug to treat inflammatory diseases

In a recent study, a research group led by Christian Gruber at MedUni Vienna's Institute of Pharmacology isolated a peptide (small protein molecule) from beetroot.

30 Oct 2020

Hospital floors create route of transfer of potentially dangerous organisms to patients

The floors of hospital rooms are quickly and frequently contaminated with antibiotic-resistant bacteria within hours of patient admission, creating a route of transfer of potentially dangerous organisms to patients, according to a study published today as part of the proceedings from Decennial 2020: The Sixth International Conference on Healthcare-Associated Infections.

30 Oct 2020

Researchers show how allergens are detected by the immune system

A key step in the immune system's response to allergens has been uncovered by researchers at Massachusetts General Hospital (MGH).

30 Oct 2020

Children with multiple islet autoantibodies are more likely to progress to type 1 diabetes

Children with multiple islet autoantibodies - biological markers of autoimmunity -- are more likely to progress to symptomatic type 1 diabetes (T1D) than those who remain positive for a single autoantibody.

30 Oct 2020

New process converts crustacean shells and wood waste into nutritional supplements

The shells of crustaceans and wood waste such as branches pruned from trees usually end up in landfills. These waste materials are given a new lease of life to become nutritional supplements and medicine, with the help of a novel process developed by researchers from the National University of Singapore (NUS).

30 Oct 2020

Human immune system may play key role in shaping the microbiome composition

The gut is an unusually noisy place, where hundreds of species of bacteria live alongside whatever microbes happen to have hitched a ride in on your lunch.

30 Oct 2020

Study: Toxins produced by tube-dwelling anemones have pharmacological potential

Researchers based in Brazil and the United States have completed the first-ever mapping exercise to profile the toxins produced by tube-dwelling anemones, or cerianthids, a family of marine animals belonging to the same phylum (Cnidaria) as sea anemones, jellyfish and corals.

30 Oct 2020

Penn State and Stanford University collaborate to develop two-hour sepsis test

One in three people who die in U.S. hospitals have sepsis, the body's extreme response to infection that can lead to multiple organ failure. Diagnosis can take up to five days, but death may take only hours from the initial onset of sepsis.

30 Oct 2020

COVID-19 patients at risk of fatal co-infection during ICU stays

Researchers in the UK have conducted a study showing that a high proportion of patients admitted to intensive care units (ICU) with coronavirus disease 2019 (COVID-19) acquire a secondary bacterial co-infection during their hospital stay.

29 Oct 2020

Toxin-carrying virus implicated in the emergence of new Salmonella strain in pigs

Researchers at the Quadram Institute have implicated a toxin-carrying virus in the emergence of a new strain of Salmonella in pigs.

29 Oct 2020

Severe ulcerative colitis linked to a newly-discovered strain of oral bacteria

Bacteria from the mouth could hold clues to understanding – and potentially treating – severe ulcerative colitis, a painful bowel disease.

29 Oct 2020

Biophysicists develop computer model that shows effect of antiseptics on bacterial membranes

A team of biophysics from leading Russian research and educational institutions (MSU, RUDN University, and the Federal Research and Clinical Center of the Federal Medical-Biological Agency of Russia) developed a computer model that shows the effect of antiseptics on bacterial membranes.

29 Oct 2020

High-sugar diet can damage the gut’s protective mucus layer, lead to worse colitis

Mice fed diets high in sugar developed worse colitis, a type of inflammatory bowel disease (IBD), and researchers examining their large intestines found more of the bacteria that can damage the gut's protective mucus layer.

28 Oct 2020

Scientists use experimental approach to identify genes and interactions

A phage is a virus that invades a bacterial cell. While harmless to human cells, phages are potentially deadly to bacteria since many phages enter a cell in order to hijack its machinery in order to reproduce itself, thus destroying the cell.

28 Oct 2020

Researchers develop a model to design vaccines, cancer immunotherapies

The body's immune system defeats diseases by sensing foreign invaders, like bacteria or viruses, and then mounting a response against them.

28 Oct 2020

Specific genes of infant gut bacterium determine its symbiotic function in the infant's gut

While an infant's genes distinguish her from other newborns, a new peer-reviewed study reports that specific genes of a particular infant gut bacterium determine its symbiotic function in the infant's gut.

28 Oct 2020

Research: Sick vampire bats socially distance themselves from groupmates

New research shows that when vampire bats feel sick, they socially distance themselves from groupmates in their roost - no public health guidance required.

28 Oct 2020

Study: Coronaviruses are adept at imitating human immune proteins involved in COVID-19

Coronaviruses are adept at imitating human immune proteins that have been implicated in severe COVID-19 disease, a study from researchers at Columbia University Vagelos College of Physicians and Surgeons has found.

28 Oct 2020

Inflammasome may play a key role in triggering immune response to cancer

The inflammasome — a protein signaling network that is activated to rid the body of virus or bacteria-infected cells — may play an important role in triggering an immune response to cancer and causing an existing class of drugs to work better against cancers.

27 Oct 2020

Antibiotic use patterns and patient transfers in hospitals may drive the emergence of drug resistance

Understanding the role of antibiotic use patterns and patient transfers in the emergence of drug-resistant microbes is essential to crafting effective prevention strategies, suggests a study published today in eLife.

27 Oct 2020

Bacteria News and Research

Beetroot peptide may be a good candidate for development of a drug to treat inflammatory diseases

Hospital floors create route of transfer of potentially dangerous organisms to patients

Researchers show how allergens are detected by the immune system

Children with multiple islet autoantibodies are more likely to progress to type 1 diabetes

New process converts crustacean shells and wood waste into nutritional supplements

Human immune system may play key role in shaping the microbiome composition

Study: Toxins produced by tube-dwelling anemones have pharmacological potential

Penn State and Stanford University collaborate to develop two-hour sepsis test

COVID-19 patients at risk of fatal co-infection during ICU stays

Toxin-carrying virus implicated in the emergence of new Salmonella strain in pigs

Severe ulcerative colitis linked to a newly-discovered strain of oral bacteria

Biophysicists develop computer model that shows effect of antiseptics on bacterial membranes

High-sugar diet can damage the gut’s protective mucus layer, lead to worse colitis

Scientists use experimental approach to identify genes and interactions

Researchers develop a model to design vaccines, cancer immunotherapies

Specific genes of infant gut bacterium determine its symbiotic function in the infant's gut

Research: Sick vampire bats socially distance themselves from groupmates

Study: Coronaviruses are adept at imitating human immune proteins involved in COVID-19

Inflammasome may play a key role in triggering immune response to cancer

Antibiotic use patterns and patient transfers in hospitals may drive the emergence of drug resistance

Microbiology eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo